A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy.
| Autor: | Patel D; Internal Medicine, Trinity West Medical Center, Steubenville, USA., Mandal G; Internal Medicine, Trinity West Medical Center, Steubenville, USA., Chukwueke L; Internal Medicine, Trinity West Medical Center, Steubenville, USA., Woods K; Infectious Disease, Trinity West Medical Center, Steubenville, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2022 May 20; Vol. 14 (5), pp. e25165. Date of Electronic Publication: 2022 May 20 (Print Publication: 2022). |
| DOI: | 10.7759/cureus.25165 |
| Abstrakt: | Chronic autoimmune demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder in which the body's immune system attacks the myelin sheaths. Myelin sheaths are the fatty insulation covering and protecting the nerves, and damage to these can lead to neurological symptoms like numbness, tingling, and weakness. CIDP is a chronic disease in the Guillain-Barré syndrome spectrum. Numerous case reports of autoimmune diseases linked to coronavirus disease 2019 (COVID-19) have been seen since the onset of COVID-19 pandemic. We present one such challenging case of COVID-19-induced CIDP. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Patel et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|